Wellington Management Group LLP Grows Stock Holdings in Enfusion, Inc. (NYSE:ENFN)

Wellington Management Group LLP raised its position in Enfusion, Inc. (NYSE:ENFN - Free Report) by 6.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 976,296 shares of the company's stock after acquiring an additional 61,032 shares during the quarter. Wellington Management Group LLP owned approximately 0.76% of Enfusion worth $9,265,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. TenCore Partners LP bought a new position in Enfusion in the 3rd quarter worth $3,938,000. Dimensional Fund Advisors LP raised its stake in Enfusion by 57.5% in the second quarter. Dimensional Fund Advisors LP now owns 524,142 shares of the company's stock worth $4,466,000 after buying an additional 191,436 shares in the last quarter. Impax Asset Management Group plc lifted its holdings in Enfusion by 25.4% in the third quarter. Impax Asset Management Group plc now owns 676,948 shares of the company's stock worth $6,424,000 after buying an additional 136,948 shares during the period. Scalar Gauge Management LLC boosted its position in Enfusion by 21.8% during the 2nd quarter. Scalar Gauge Management LLC now owns 613,513 shares of the company's stock valued at $5,227,000 after acquiring an additional 110,000 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new position in shares of Enfusion during the 3rd quarter worth approximately $892,000. 81.05% of the stock is owned by institutional investors.

Insider Activity

In related news, COO Neal Pawar sold 21,801 shares of the stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $10.03, for a total transaction of $218,664.03. Following the sale, the chief operating officer now directly owns 1,143,544 shares of the company's stock, valued at approximately $11,469,746.32. This represents a 1.87 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 36.44% of the company's stock.

Enfusion Stock Performance

Shares of ENFN traded down $0.04 on Monday, reaching $10.61. The stock had a trading volume of 567,420 shares, compared to its average volume of 383,757. The firm has a market capitalization of $1.36 billion, a price-to-earnings ratio of 266.25, a price-to-earnings-growth ratio of 3.98 and a beta of 0.97. The company has a 50-day simple moving average of $9.53 and a 200-day simple moving average of $8.95. Enfusion, Inc. has a 12-month low of $7.52 and a 12-month high of $10.74.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.